Austin, Texas– Vellum Health, a mobile healthcare company focused on intravenous (IV) care delivery, has secured Series A funding to expand its operations and roll out a new unified brand and technology platform. The round was led by FCA Venture Partners, with participation from Green Park & Golf Ventures and several early-stage angel investors.
The company’s platform offers bedside IV access, infusion therapy, and transfusion services across skilled nursing facilities, long-term care centers, and patients’ homes. The goal is to shift complex care away from hospitals and into lower-cost, more accessible settings—reducing unnecessary admissions and improving outcomes for patients with chronic or acute conditions.
The funding will support national expansion and further development of Vellum’s AI-driven platform, which integrates with electronic medical records (EMRs) and helps coordinate care across providers and payors. The platform also enables dynamic documentation, patient identification, and care navigation in real time.
CEO Tyler Payne said the investment marks a critical step in scaling the company’s mobile-first model. “We’re delivering expert clinical care where and when it’s needed most,” he said. “This funding helps us grow our footprint while strengthening our commitment to high-quality, tech-enabled care.”
The company also announced it has consolidated several vascular access businesses under the Vellum Health brand to streamline operations and branding.
Matt King, Managing Partner at FCA Venture Partners, called Vellum’s approach well-suited to today’s healthcare needs. “They’re solving real logistical and clinical gaps with a scalable, patient-centered model,” he said.
Vellum Health currently operates in multiple U.S. states and works with hospitals, insurers, and post-acute care providers to extend care into patients’ homes and residential facilities.
